SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: PDL who wrote (638)10/18/1999 9:04:00 PM
From: Eclectus  Read Replies (1) | Respond to of 1298
 
I am one shareholder who will not approve this agreement. Genzyme will have to go much further for me...



To: PDL who wrote (638)12/2/1999 7:38:00 PM
From: Ken Reidy  Read Replies (1) | Respond to of 1298
 
Now that the value of CEGE's holdings in ABGX have exploded to over $250,000,000, does anybody believe that GENZ's bargain may have just flew out the window. Doesn't CEGE's board have a fiduciary responsibility to CEGE shareholders to reject this offer now? I think it is time to buy CEGE....minimal downside risk and much better chance that we will get more than $10 a share. Or am I just dreaming?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News